{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T20:04:19Z","timestamp":1781381059331,"version":"3.54.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1016\/j.jneuroim.2006.05.002","type":"journal-article","created":{"date-parts":[[2006,6,13]],"date-time":"2006-06-13T10:50:55Z","timestamp":1150195855000},"page":"18-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Neuropeptide Y Y1 receptors mediate morphine-induced reductions of natural killer cell activity"],"prefix":"10.1016","volume":"177","author":[{"given":"Timothy B.","family":"Saurer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie G.","family":"Ijames","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald T.","family":"Lysle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2006.05.002_bib1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/0006-8993(86)90281-7","article-title":"Mu receptors at discrete hypothalamic and brainstem sites mediate opioid peptide-induced increases in central sympathetic outflow","volume":"378","author":"Appel","year":"1986","journal-title":"Brain Res."},{"key":"10.1016\/j.jneuroim.2006.05.002_bib2","first-page":"273","article-title":"Suppression of lymphocyte activity after acute morphine administration appears to be glucocorticoid independent","volume":"325","author":"Bayer","year":"1990","journal-title":"Prog. Clin. Biol. Res."},{"key":"10.1016\/j.jneuroim.2006.05.002_bib3","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0165-5728(01)00328-9","article-title":"Differential effects of neuropeptide Y (NPY) on leukocyte subsets in the blood: mobilization of B-1-like B-lymphocytes and activated monocytes","volume":"117","author":"Bedoui","year":"2001","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2006.05.002_bib4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0165-5728(02)00278-3","article-title":"NPY modulates epinephrine-induced leukocytosis via Y-1 and Y-5 receptor activation in vivo: sympathetic co-transmission during leukocyte mobilization","volume":"132","author":"Bedoui","year":"2002","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2006.05.002_bib5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0165-5728(94)90064-7","article-title":"Central alpha-adrenergic involvement in morphine-mediated suppression of splenic natural killer activity","volume":"53","author":"Carr","year":"1994","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2006.05.002_bib6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0167-0115(96)00074-2","article-title":"BIBP 3226, the first selective neuropeptide Y1 receptor antagonist: a review of its pharmacological properties","volume":"65","author":"Doods","year":"1996","journal-title":"Regul. Pept."},{"key":"10.1016\/j.jneuroim.2006.05.002_bib8","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1006\/cimm.1999.1534","article-title":"Phenotypic analysis of splenocyte subsets following acute morphine treatment in the rat","volume":"195","author":"Fecho","year":"1999","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.jneuroim.2006.05.002_bib7","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0022-3565(25)38238-8","article-title":"Evidence for beta-adrenergic-receptor involvement in the immunomodulatory effects of morphine","volume":"265","author":"Fecho","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jneuroim.2006.05.002_bib9","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0022-3565(25)12317-3","article-title":"Assessment of the involvement of central nervous system and peripheral opioid receptors in the immunomodulatory effects of acute morphine treatment in rats","volume":"276","author":"Fecho","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jneuroim.2006.05.002_bib10","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0022-3565(25)12916-9","article-title":"Evidence for sympathetic and adrenal involvement in the immunomodulatory effects of acute morphine treatment in rats","volume":"277","author":"Fecho","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jneuroim.2006.05.002_bib12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/jnr.490180108","article-title":"Noradrenergic sympathetic innervation of the spleen: II. Tyrosine hydroxylase (TH)-positive nerve terminals form synapticlike contacts on lymphocytes in the splenic white pulp","volume":"18","author":"Felten","year":"1987","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.jneuroim.2006.05.002_bib11","doi-asserted-by":"crossref","first-page":"755s","DOI":"10.4049\/jimmunol.135.2.755","article-title":"Noradrenergic and peptidergic innervation of lymphoid tissue","volume":"135","author":"Felten","year":"1985","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2006.05.002_bib13","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S0022-3565(25)22517-4","article-title":"A mechanism of action for morphine-induced immunosuppression: corticosterone mediates morphine-induced suppression of natural killer cell activity","volume":"270","author":"Freier","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jneuroim.2006.05.002_bib14","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1006\/brbi.1995.1017","article-title":"Neuropeptide Y inhibits in vivo specific antibody production in rats","volume":"9","author":"Friedman","year":"1995","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jneuroim.2006.05.002_bib15","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1056\/NEJM197208102870620","article-title":"Susceptibility of addicts to infection and neoplasia","volume":"287","author":"Harris","year":"1972","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2006.05.002_bib16","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/S0022-3565(25)39585-6","article-title":"Immunosuppression by morphine is mediated by central pathways","volume":"267","author":"Hernandez","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jneuroim.2006.05.002_bib17","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/0002-9343(50)90021-0","article-title":"Infections resulting from narcotic addiction: report of 102 cases","volume":"9","author":"Hussey","year":"1950","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jneuroim.2006.05.002_bib19","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0022-3565(25)12679-7","article-title":"Sympathetic nervous system mediates central corticotropin-releasing factor induced suppression of natural killer cytotoxicity","volume":"255","author":"Irwin","year":"1990","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jneuroim.2006.05.002_bib18","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1096\/fasebj.5.15.1743441","article-title":"Neuropeptide Y and natural killer cell activity: findings in depression and Alzheimer caregiver stress","volume":"5","author":"Irwin","year":"1991","journal-title":"FASEB J."},{"key":"10.1016\/j.jneuroim.2006.05.002_bib20","first-page":"43","article-title":"Stress and morphine affect survival of rats challenged with a mammary ascites tumor (MAT 13762B)","volume":"3","author":"Lewis","year":"1983","journal-title":"Nat. Immun. Cell Growth Regul."},{"key":"10.1016\/j.jneuroim.2006.05.002_bib21","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1016\/S0024-3205(02)02087-8","article-title":"Immunosuppression induced by central action of morphine is not blocked by mifepristone (RU 486)","volume":"71","author":"Liang-Suo","year":"2002","journal-title":"Life Sci."},{"key":"10.1016\/j.jneuroim.2006.05.002_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-67-1-1","article-title":"The major medical complications of heroin addiction","volume":"67","author":"Louria","year":"1967","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jneuroim.2006.05.002_bib23","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1001\/archinte.1949.00220350063005","article-title":"Endocarditis in \u201cmain line\u201d opium addicts","volume":"83","author":"Luttgens","year":"1949","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.jneuroim.2006.05.002_bib24","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/S0022-3565(25)13105-4","article-title":"Evidence for the involvement of the caudal region of the periaqueductal gray in a subset of morphine-induced alterations of immune status","volume":"277","author":"Lysle","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jneuroim.2006.05.002_bib25","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1016\/0006-2952(87)90567-3","article-title":"Binding of naloxone to human T lymphocytes","volume":"36","author":"Madden","year":"1987","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jneuroim.2006.05.002_bib26","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0196-9781(00)00284-9","article-title":"Age-related changes in the neuropeptide Y effects on murine lymphoproliferation and interleukin-2 production","volume":"21","author":"Medina","year":"2000","journal-title":"Peptides"},{"key":"10.1016\/j.jneuroim.2006.05.002_bib27","first-page":"65","article-title":"Involvement of neuropeptide Y in neuroendocrine stress responses. Central and peripheral studies","volume":"29","author":"Mormede","year":"1990","journal-title":"J. Neural Transm., Suppl."},{"key":"10.1016\/j.jneuroim.2006.05.002_bib28","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1006\/brbi.1993.1007","article-title":"Effect of neuropeptide Y on natural killer activity of normal human lymphocytes","volume":"7","author":"Nair","year":"1993","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jneuroim.2006.05.002_bib29","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1986"},{"key":"10.1016\/j.jneuroim.2006.05.002_bib30","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0165-5728(94)90234-8","article-title":"Molecular cloning of NPY-Y1 receptor cDNA from rat splenic lymphocytes: evidence of low levels of mRNA expression and [125I]NPY binding sites","volume":"54","author":"Petitto","year":"1994","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2006.05.002_bib31","doi-asserted-by":"crossref","first-page":"12304","DOI":"10.1073\/pnas.92.26.12304","article-title":"Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the \u201cshell\u201d as compared with the \u201ccore\u201d of the rat nucleus accumbens","volume":"92","author":"Pontieri","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2006.05.002_bib32","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0022-1759(84)90154-6","article-title":"The standardization of Nk cell assays for use in studies of biological response modifiers","volume":"68","author":"Pross","year":"1984","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jneuroim.2006.05.002_bib33","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/0889-1591(91)90011-X","article-title":"Neuropeptide-Y innervation of the rat spleen: another potential immunomodulatory neuropeptide","volume":"5","author":"Romano","year":"1991","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jneuroim.2006.05.002_bib34","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jneuroim.2005.11.009","article-title":"Suppression of natural killer cell activity by morphine is mediated by the nucleus accumbens shell","volume":"173","author":"Saurer","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2006.05.002_bib35","doi-asserted-by":"crossref","first-page":"7114","DOI":"10.1073\/pnas.83.18.7114","article-title":"Involvement of brain opiate receptors in the immune-suppressive effect of morphine","volume":"83","author":"Shavit","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2006.05.002_bib36","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3109\/00207459108987189","article-title":"Norepinephrine inhibits human natural killer cell activity in vitro","volume":"58","author":"Takamoto","year":"1991","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.jneuroim.2006.05.002_bib37","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/infdis\/148.4.656","article-title":"Effect of morphine on resistance to infection","volume":"148","author":"Tubaro","year":"1983","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jneuroim.2006.05.002_bib38","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0024-3205(98)00349-X","article-title":"Modulation of innate immune functions by intracerebroventricularly applied neuropeptide Y: dose and time dependent effects","volume":"63","author":"von Horsten","year":"1998","journal-title":"Life Sci."},{"key":"10.1016\/j.jneuroim.2006.05.002_bib39","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1126\/science.2749256","article-title":"The periaqueductal gray-matter mediates opiate-induced immunosuppression","volume":"245","author":"Weber","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.jneuroim.2006.05.002_bib40","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.4049\/jimmunol.123.3.1068","article-title":"Suggestive evidence for receptors for morphine and methionine\u2013enkephalin on normal human blood T lymphocytes","volume":"123","author":"Wybran","year":"1979","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2006.05.002_bib41","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/00000542-199509000-00008","article-title":"Morphine inhibits spontaneous and cytokine-enhanced natural killer cell cytotoxicity in volunteers","volume":"83","author":"Yeager","year":"1995","journal-title":"Anesthesiology"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572806001639?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572806001639?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:03:41Z","timestamp":1759046621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572806001639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":41,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S0165572806001639"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2006.05.002","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuropeptide Y Y1 receptors mediate morphine-induced reductions of natural killer cell activity","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2006.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}